A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection.
Moss RB; Hansen C; Sanders RL; Hawley S; Li T; Steigbigel RT; The Journal Of Infectious Diseases, 2012, vol. 206, issue 12, p 1844, ISSN 15376613. ISBN 15376613.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef